GO:0008112 nicotinamide N-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008112 describes the enzymatic activity that transfers a methyl group from S-adenosyl-L-methionine to nicotinamide, producing 1-methylnicotinamide and S-adenosyl-L-homocysteine.
• The reaction is catalyzed by nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that consumes methyl groups and regulates nicotinamide availability.
• NNMT activity influences obesity, liver disease, cardiovascular disease, and cancer by altering NAD+ metabolism and epigenetic methylation potential.
• In cancer-associated fibroblasts, NNMT activity can suppress antitumor immunity, and its inhibition restores immune surveillance.
• NNMT is regulated by post-translational modifications such as citrullination, which inactivates the enzyme.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect NNMT function in health and disease.
Description
Nicotinamide N-methyltransferase activity (GO:0008112) is a molecular function that catalyzes the methylation of nicotinamide using S-adenosyl-L-methionine (SAM) as the methyl donor, yielding 1-methylnicotinamide and S-adenosyl-L-homocysteine. This reaction is the first and rate-limiting step in the nicotinamide catabolic pathway and is primarily executed by the enzyme nicotinamide N-methyltransferase (NNMT). Because nicotinamide is a precursor of NAD+, NNMT activity directly influences cellular NAD+ levels and the availability of methyl groups for other methylation reactions. Researchers study GO:0008112 because it sits at the intersection of metabolism, epigenetics, and disease. NNMT is overexpressed in multiple cancers, where it promotes a pro-tumorigenic microenvironment and immune evasion. In metabolic disorders, NNMT knockdown protects against diet-induced obesity in mice, highlighting its role in energy homeostasis. In liver diseases, NNMT modulates lipid metabolism and inflammation, making it a potential therapeutic target. In cardiovascular diseases, NNMT is emerging as a metabolic regulator with diagnostic and therapeutic potential. Understanding the precise molecular mechanism, regulation, and disease relevance of GO:0008112 requires robust experimental models. CRISPR gene editing enables the creation of knockout, point-mutation, knock-in, and overexpression cell lines to interrogate NNMT function in a controlled manner. This article provides a comprehensive overview of the term, its associated genes, regulatory mechanisms, disease links, and state-of-the-art research methods.
nicotinamide N-methyltransferase activity At A Glance
| GO ID | GO:0008112 |
|---|---|
| GO term | nicotinamide N-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | nicotinamide methyltransferase activity; S-adenosyl-L-methionine:nicotinamide N-methyltransferase activity |
| Definition | Catalysis of the reaction: S-adenosyl-L-methionine(1+) + nicotinamide = 1-methylnicotinamide + S-adenosyl-L-homocysteine. |
| Major function | Methylation of nicotinamide to 1-methylnicotinamide, regulating NAD+ and methylation potential. |
| EC number | 2.1.1.1 |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Subcellular location | Cytosol |
What Is GO:0008112?
GO:0008112, nicotinamide N-methyltransferase activity, is defined as the catalysis of the reaction: S-adenosyl-L-methionine(1+) + nicotinamide = 1-methylnicotinamide + S-adenosyl-L-homocysteine. In other words, it is the enzyme activity that transfers a methyl group from SAM to nicotinamide, producing 1-methylnicotinamide and SAH. This activity is synonymous with nicotinamide methyltransferase activity and S-adenosyl-L-methionine:nicotinamide N-methyltransferase activity. It is a molecular function classified under transferase activity, specifically methyltransferase activity.
Why Is nicotinamide N-methyltransferase activity Important in Cell Biology?
GO:0008112 is important because it controls a critical node in nicotinamide and NAD+ metabolism, influencing energy expenditure, epigenetic methylation, and cellular stress responses. Dysregulation of this activity is implicated in obesity, liver steatosis, cardiovascular disease, and multiple cancers, where it can reprogram the tumor microenvironment and suppress antitumor immunity. Targeting NNMT activity is therefore a promising therapeutic strategy, and precise CRISPR models are needed to validate its causal roles.
• Regulates NAD+ salvage pathway by consuming nicotinamide, affecting cellular redox and energy metabolism.
• Modulates epigenetic methylation potential by consuming SAM and producing SAH, influencing histone and DNA methylation.
• Protects against diet-induced obesity: NNMT knockdown increases energy expenditure in mice.
• Promotes cancer progression by supporting cancer-associated fibroblast phenotypes and immune evasion.
• Involved in liver diseases such as nonalcoholic steatohepatitis and hepatocellular carcinoma.
• Emerging role in cardiovascular diseases as a metabolic regulator and therapeutic target.
• Post-translational citrullination inactivates NNMT, providing a regulatory switch.
• Serves as a biomarker and therapeutic target in multiple malignancies.
• Key enzyme for nicotinamide catabolism, affecting drug metabolism and toxicity.
• Enables metabolic reprogramming in cancer-associated fibroblasts and macrophages.
Molecular Mechanism of nicotinamide N-methyltransferase activity
Substrate Binding and Catalysis
In simple terms: NNMT grabs a nicotinamide molecule and a SAM molecule, then transfers a methyl group from SAM to nicotinamide.
NNMT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide, forming 1-methylnicotinamide and S-adenosyl-L-homocysteine (SAH). The enzyme binds both substrates in an ordered manner, with nicotinamide binding first, followed by SAM. The reaction proceeds via a ternary complex, and the methyl transfer occurs through an SN2-like mechanism. This activity is essential for nicotinamide clearance and for maintaining cellular methylation balance.
Cofactor Requirements and Kinetics
In simple terms: SAM is the methyl donor, and the reaction produces SAH, which can inhibit the enzyme.
SAM serves as the methyl donor and is converted to SAH. NNMT activity is dependent on the availability of SAM, and SAH acts as a competitive inhibitor, linking enzyme activity to the cellular methylation potential. Kinetic studies have shown that NNMT follows a sequential ordered Bi-Bi mechanism. The enzyme is cytosolic and functions as a monomer.
Post-translational Regulation by Citrullination
In simple terms: Adding a citrulline modification to NNMT can turn the enzyme off.
Citrullination of NNMT at specific arginine residues by peptidylarginine deiminases (PADs) inactivates the enzyme, reducing its methyltransferase activity. This modification alters the enzyme's charge and structure, leading to loss of function. This regulatory mechanism may contribute to disease pathogenesis by dysregulating nicotinamide metabolism.
Role in NAD+ Metabolism and Methylation Potential
In simple terms: By consuming nicotinamide, NNMT affects how much NAD+ the cell can make and how many methyl groups are available for other reactions.
NNMT competes with NAD+ salvage enzymes for nicotinamide, thereby reducing NAD+ synthesis. Additionally, the consumption of SAM and production of SAH by NNMT can inhibit other methyltransferases, affecting epigenetic marks such as histone methylation. This dual role makes NNMT a key metabolic regulator.
Key Genes Involved in GO:0008112 nicotinamide N-methyltransferase activity
The following genes and proteins are directly or indirectly involved in nicotinamide N-methyltransferase activity and its regulatory network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NNMT | Catalyzes the methylation of nicotinamide | Primary enzyme for GO:0008112; target for obesity, cancer, and liver disease |
| SAM | Methyl donor for the reaction | Cofactor; levels influence NNMT activity |
| SAH | Product and competitive inhibitor | Feedback regulation of NNMT |
| NAMPT | NAD+ salvage enzyme competing for nicotinamide | Cross-talk with NNMT affects NAD+ levels |
| NMNAT | Converts NMN to NAD+ | Downstream of nicotinamide salvage |
| PADI | Citrullinates NNMT, inactivating it | Post-translational regulation |
| MAT1A | Synthesizes SAM in liver | Provides methyl donor for NNMT |
| GNMT | Competes for SAM | Affects methylation potential |
| AHCY | Hydrolyzes SAH to adenosine and homocysteine | Regulates SAH levels and NNMT inhibition |
| CYP2E1 | Metabolizes nicotinamide and other substrates | Indirect interaction with NNMT pathway |
| PARP1 | Consumes NAD+ | Competes with NNMT for NAD+ precursors |
| SIRT1 | NAD+-dependent deacetylase | Affected by NAD+ levels modulated by NNMT |
| PPARα | Transcription factor regulated by NNMT | Mediates effects on lipid metabolism |
| PPARγ | Transcription factor in adipocytes | Linked to NNMT in obesity |
| FGF21 | Hormone regulating energy expenditure | Upregulated upon NNMT knockdown |
| IL-6 | Cytokine in tumor microenvironment | Associated with NNMT in cancer-associated fibroblasts |
| TGF-β | Cytokine driving fibrosis | Interacts with NNMT in liver disease |
| α-SMA | Fibroblast activation marker | Used to assess NNMT effects in CAFs |
How Is nicotinamide N-methyltransferase activity Regulated?
NNMT activity is regulated at multiple levels. Transcriptionally, NNMT expression is induced by stress, cytokines, and metabolic signals. Post-translationally, citrullination by PAD enzymes inactivates NNMT. Metabolically, the availability of SAM and nicotinamide, as well as the accumulation of SAH, feedback-regulates enzyme activity. In cancer-associated fibroblasts, NNMT expression is upregulated by tumor-derived factors, and its inhibition restores antitumor immunity. In hepatocytes, palmitate-induced PPAR transactivation involves NNMT upregulation.
nicotinamide N-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NNMT | Obesity and insulin resistance | Knockout mouse, adipocyte-specific KO |
| NNMT | Lung adenocarcinoma metastasis | CAF-specific knockout or overexpression in co-culture |
| NNMT | Gastric cancer microenvironment | Macrophage-fibroblast co-culture with NNMT KO |
| NNMT | Liver steatosis and NASH | Hepatocyte-specific knockout or overexpression |
| NNMT | Cardiovascular disease | Vascular smooth muscle cell KO and overexpression |
Obesity and Metabolic Disorders
NNMT knockdown protects against diet-induced obesity by increasing energy expenditure and upregulating FGF21. NNMT activity influences adipocyte metabolism and insulin sensitivity, making it a target for metabolic syndrome.
Cancer and Tumor Microenvironment
NNMT is overexpressed in many cancers, including lung adenocarcinoma and gastric cancer, where it promotes cancer-associated fibroblast phenotypes and immune evasion. In lung adenocarcinoma, NNMT negatively regulates the metastasis-promoting property of CAFs. In gastric cancer, NNMT-mediated nicotinamide metabolism shapes the macrophage-fibroblast interplay. NNMT inhibition in CAFs restores antitumor immunity.
Liver Diseases
NNMT is implicated in nonalcoholic fatty liver disease, steatohepatitis, and hepatocellular carcinoma. It modulates lipid metabolism and inflammation in hepatocytes, partly through PPAR signaling. NNMT upregulation contributes to palmitate-elicited PPAR transactivation.
Cardiovascular Diseases
NNMT is emerging as a metabolic regulator in cardiovascular diseases, influencing vascular smooth muscle cell function and cardiac remodeling. Its role in NAD+ metabolism and methylation may contribute to atherosclerosis and heart failure.
From nicotinamide N-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NNMT loss protect against diet-induced obesity? | Whole-body or adipocyte-specific NNMT knockout mouse |
| Does NNMT in CAFs suppress antitumor immunity? | CAF-specific NNMT knockout in syngeneic tumor models |
| How does NNMT citrullination affect enzyme activity? | Point mutation of arginine residues to citrulline mimics |
| What is the effect of NNMT overexpression in hepatocytes? | Adenoviral or transgenic NNMT overexpression in liver |
| Can NNMT inhibition reprogram the tumor microenvironment? | Pharmacological inhibitor or CRISPR KO in co-culture |
| Does NNMT regulate NAD+ levels in cardiomyocytes? | Cardiomyocyte-specific NNMT KO and NAD+ measurement |
How to Study the nicotinamide N-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Nicotinamide, 1-methylnicotinamide, NAD+, SAM, SAH | Quantify NNMT activity in cells/tissues |
| Radiometric enzyme assay | Conversion of 14C-nicotinamide to 1-methylnicotinamide | Measure NNMT kinetics and inhibition |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identify modifiers of NNMT dependence |
| RNA-seq | Transcriptional changes | Assess NNMT-dependent gene expression |
| ChIP-seq | Histone methylation marks | Link NNMT to epigenetic regulation |
| Western blot | NNMT protein levels and citrullination | Validate knockout/overexpression |
| Immunohistochemistry | NNMT expression in tissues | Correlate with disease stage |
| Co-culture assays | Immune cell-fibroblast interactions | Study NNMT in tumor microenvironment |
Enzymatic Activity Assays
NNMT activity can be measured using radiometric or mass spectrometry-based assays that quantify the conversion of nicotinamide to 1-methylnicotinamide in the presence of SAM. These assays are used to validate enzyme kinetics and inhibitor efficacy.
Metabolomics and NAD+ Quantification
LC-MS/MS-based metabolomics can measure nicotinamide, 1-methylnicotinamide, NAD+, SAM, and SAH levels to assess NNMT activity in cells and tissues. This approach reveals metabolic reprogramming upon NNMT modulation.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify synthetic lethal interactions and modifiers of NNMT activity. Pooled screens with NNMT-targeting sgRNAs enable discovery of resistance mechanisms.
Transcriptomics and Epigenomics
RNA-seq and ChIP-seq can reveal transcriptional changes and histone methylation patterns altered by NNMT activity. These methods help link NNMT to epigenetic regulation.
How CRISPR Can Be Used to Study GO:0008112 nicotinamide N-methyltransferase activity
Knockout
CRISPR knockout of NNMT using Cas9 and sgRNAs targeting early exons generates loss-of-function cell lines and animal models. These models are used to study the effects of NNMT deficiency on obesity, cancer, and liver disease. Knockout validation is typically performed by western blot and activity assays.
Point Mutation
Point mutations can be introduced into the NNMT catalytic domain to abrogate enzymatic activity without affecting protein stability. For example, mutating the arginine residues targeted by citrullination can mimic inactivation. These models help distinguish catalytic activity from scaffolding functions.
Knock-in
Knock-in of tagged NNMT (e.g., FLAG, HA, or GFP) allows for affinity purification, imaging, and interactome studies. Knock-in of disease-associated variants can model human mutations. CRISPR-mediated knock-in in cell lines or mice enables precise expression control.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of NNMT is used to study gain-of-function effects in cancer and metabolic cells. Overexpression models help identify downstream pathways and therapeutic vulnerabilities.
How EDITGENE Supports nicotinamide N-methyltransferase activity Research
Researchers studying nicotinamide N-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for nicotinamide N-methyltransferase activity research.
Frequently Asked Questions About nicotinamide N-methyltransferase activity
What is nicotinamide N-methyltransferase activity?
It is the enzyme activity (GO:0008112) that transfers a methyl group from SAM to nicotinamide, producing 1-methylnicotinamide and SAH, primarily catalyzed by NNMT.
What genes are involved in nicotinamide N-methyltransferase activity?
The primary gene is NNMT, but related genes include NAMPT, NMNAT, MAT1A, GNMT, AHCY, and PADI, which influence substrate availability and regulation.
What diseases are associated with NNMT activity?
NNMT activity is linked to obesity, liver diseases, cardiovascular diseases, and multiple cancers including lung and gastric cancer.
How is NNMT activity regulated?
NNMT is regulated transcriptionally by metabolic and inflammatory signals, and post-translationally by citrullination, which inactivates the enzyme.
What is the role of NNMT in cancer?
NNMT promotes cancer progression by supporting cancer-associated fibroblast phenotypes, immune evasion, and metabolic reprogramming.
Can NNMT be targeted therapeutically?
Yes, NNMT inhibitors and genetic knockdown have shown efficacy in preclinical models of obesity, cancer, and liver disease.
What are the substrates and products of NNMT?
The substrates are S-adenosyl-L-methionine and nicotinamide; the products are 1-methylnicotinamide and S-adenosyl-L-homocysteine.
How can I study NNMT activity in the lab?
You can use enzymatic assays, metabolomics, CRISPR knockout/overexpression models, and RNA-seq to measure NNMT activity and its downstream effects.
What is the difference between NNMT and NAMPT?
NNMT methylates nicotinamide for excretion, while NAMPT recycles nicotinamide to NAD+; they compete for the same substrate.
Is NNMT activity involved in epigenetic regulation?
Yes, by consuming SAM and producing SAH, NNMT activity can alter the methylation potential and affect histone and DNA methylation.
Conclusion
GO:0008112, nicotinamide N-methyltransferase activity, is a central metabolic enzyme activity with far-reaching implications for obesity, liver disease, cardiovascular disease, and cancer. Its regulation by substrate availability and post-translational modifications, particularly citrullination, adds layers of complexity. CRISPR-based models are indispensable for dissecting the causal roles of NNMT in these diseases. EDITGENE offers a full suite of services to support researchers in this endeavor, from knockout to library screening.
References
- 1. Kraus D et al.. 2014. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.. Nature 508(7495):258-62 PMID: 24717514
- 2. Wang P et al.. 2025. Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma.. Cancer Commun (Lond) 45(2):110-137 PMID: 39623600
- 3. Jiang Y et al.. 2024. Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer.. Cell Metab 36(8):1806-1822.e11 PMID: 38897198
- 4. Liang G et al.. 2023. Nicotinamide N-methyltransferase and liver diseases.. Genes Dis 10(5):1883-1893 PMID: 37492717
- 5. Heide J et al.. 2025. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity.. Nature 645(8082):1051-1059 PMID: 40702186
- 6. Jawaria et al.. 2025. Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target.. Biomolecules 15(9) PMID: 41008588
- 7. Nemmara VV et al.. 2018. Citrullination Inactivates Nicotinamide- N-methyltransferase.. ACS Chem Biol 13(9):2663-2672 PMID: 30044909
- 8. Song Q et al.. 2023. Nicotinamide N-methyltransferase upregulation contributes to palmitate-elicited peroxisome proliferator-activated receptor transactivation in hepatocytes.. Am J Physiol Cell Physiol 325(1):C29-C41 PMID: 37212549
